Company profile
TRAFALGAR INTERNATIONAL, INC. CIK 1695473
Ticker
GCAN (OTC)
Industry
Pharmaceutical Preparations
Headquarters
Miami, FL 33131
Fiscal year end
2025 (FY)
Key Financials
Revenue
—
Net income
-$331.6K
Total assets
$815
Total liabilities
$742.5K
Stockholders' equity
-$741.6K
Cash & equivalents
—
Operating income
-$183.0K
Operating cash flow
-$60.2K
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-03-31. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
91,099.9%
Equity / assets
-90,999.9%
CapEx / revenue
—
Operating cash flow / net income
0.18×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
—
-$331.6K
$815
$742.5K
-$741.6K
2024
—
-$179.0K
$57.8K
$898.1K
-$840.3K
2023
—
-$188.4K
$172.3K
$833.5K
-$661.2K
2022
—
-$360.3K
$280.4K
$825.3K
-$544.8K
2021
$12.6K
-$602.2K
$392.9K
$862.0K
-$469.1K
Company Details
SIC code
2834
State of incorporation
FL
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-14
Financials filed via
Form 10-K
filed 2026-03-31
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Miami, FL 33131
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:26 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.